Literature DB >> 7940987

Biotransformation of organic nitrates and vascular smooth muscle cell function.

B M Bennett1, B J McDonald, R Nigam, W C Simon.   

Abstract

The organic nitrates are interesting examples of drugs that undergo biotransformation at their site of action to generate the active form of the drug. Furthermore, tolerance to the vasodilator effects of organic nitrates is associated with impairment of this metabolic activation process. Despite considerable research effort, the intracellular processes and the chemical reaction pathways by which organic nitrates are converted to their active form are still unresolved. This review by Brian Bennett and colleagues summarizes the characteristics of organic-nitrate biotransformation in vascular smooth muscle, the difficulties encountered when assessing this biotransformation, and the evidence for the role of two identified vascular biotransformation systems (glutathione-S-transferases and the cytochrome P450 system) in the metabolic activation of organic nitrates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940987     DOI: 10.1016/0165-6147(94)90319-0

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  24 in total

1.  In vitro metabolism of chlorpromazine by cytochromes P450 4F4 and 4F5 and the inhibitory effect of imipramine.

Authors:  C L Boehme; H W Strobel
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

2.  In vitro organic nitrate bioactivation to nitric oxide by recombinant aldehyde dehydrogenase 3A1.

Authors:  Shunxin Lin; Nathaniel A Page; Sun Mi Fung; Ho-Leung Fung
Journal:  Nitric Oxide       Date:  2013-10-11       Impact factor: 4.427

3.  Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.

Authors:  A Friebe; G Schultz; D Koesling
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

4.  Formation of the NO donors glyceryl mononitrate and glyceryl mononitrite from the reaction of peroxynitrite with glycerol.

Authors:  C R White; D Moellering; R P Patel; M Kirk; S Barnes; V M Darley-Usmar
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Characterization of furoxans as a new class of tolerance-resistant nitrovasodilators.

Authors:  M Hecker; W Vorhoff; A T Bara; P I Mordvintcev; R Busse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

Review 6.  Clinical pharmacology and therapeutics.

Authors:  A Breckenridge
Journal:  BMJ       Date:  1995-02-11

7.  Effect of overexpression of human aldehyde dehydrogenase 2 in LLC-PK1 cells on glyceryl trinitrate biotransformation and cGMP accumulation.

Authors:  Y D'Souza; Y Ji; B M Bennett
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

8.  An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation.

Authors:  Zhiqiang Chen; Matthew W Foster; Jian Zhang; Lan Mao; Howard A Rockman; Toshihiro Kawamoto; Kyoko Kitagawa; Keiichi I Nakayama; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

9.  Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.

Authors:  Cynthia Sung; Tom J Parry; Todd A Riccobene; Angela Mahoney; Viktor Roschke; James Murray; Mi Li Gu; Jeffrey K Glenn; Florence Caputo; Cindy Farman; Daniel J Odenheimer
Journal:  AAPS PharmSci       Date:  2002

Review 10.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.